Cogentix Medical (NASDAQ:CGNT) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c” rating in a research note issued to investors on Thursday, November 9th.
Several other analysts have also issued reports on the company. Roth Capital assumed coverage on Cogentix Medical in a report on Wednesday, November 8th. They set a “buy” rating and a $4.00 target price on the stock. JMP Securities assumed coverage on Cogentix Medical in a report on Friday, October 6th. They set an “outperform” rating and a $5.00 target price on the stock. Finally, Zacks Investment Research lowered Cogentix Medical from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd.
Cogentix Medical (NASDAQ CGNT) traded down $0.12 during mid-day trading on Thursday, hitting $2.73. The stock had a trading volume of 369,682 shares, compared to its average volume of 62,193. Cogentix Medical has a 52 week low of $1.55 and a 52 week high of $3.26.
ILLEGAL ACTIVITY WARNING: This article was reported by BBNS and is the property of of BBNS. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://baseballnewssource.com/markets/cogentix-medical-inc-cgnt-upgraded-by-thestreet-to-c/1769322.html.
Cogentix Medical Company Profile
Cogentix Medical, Inc is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB).
Receive News & Ratings for Cogentix Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical Inc. and related companies with our FREE daily email newsletter.